Literature DB >> 21607819

Local recurrence after intended curative excision of presacral lesions: causes and preventions.

Xian Hua Gao1, Wei Zhang, Chuan Gang Fu, Lian Jie Liu, En Da Yu, Rong Gui Meng.   

Abstract

OBJECTIVE: This study was designed to explore causes for local recurrence of presacral lesions after intended curative surgery and discuss prevention strategies.
METHODS: Medical data of presacral lesions in our hospital from January 2001 to September 2009 were retrospectively studied, including preoperative examinations, intraoperative findings, and postoperative histopathologies.
RESULTS: Of 39 patients (29 women and 10 men) with presacral lesions, who ranged in age from 14 to 71 (mean, 39.56) years, 7 patients were diagnosed with recurrent presacral lesions on admission. Preoperative pelvic MRI, pelvic CT, and endorectal ultrasonography (ERUS) were performed in 23, 22, and 8 cases, respectively. MRI/CT showed that five cases had two coexisting lesions and three cases had lobulated or dumbbell shaped lesions, all of which were confirmed by intraoperative findings. ERUS suspected involvement of the rectal wall in three cases: adhesion to the rectal wall in two cases, and tumor invasion in the remaining case. During the operation, 26, 8, and 2 cases were resected by the transsacral, transabdominal, and combined abdominosacral approach, respectively. Four patients underwent simultaneous coccygectomy, and three patients received simultaneous resection of the sacrum and coccyx. Simultaneous partial resection of the invaded sigmoid colon or rectum was performed in two patients, respectively. By postoperative pathological examination, three cases were found to have ruptured cystic lesions, three had previous cyst rupture history, and five had infected lesions.
CONCLUSIONS: Presacral lesions are likely to be multiple, lobulated, infected, ruptured, and adhesive to the sacrococcyx and rectum, which contribute to the high local recurrence rate. Preoperative CT/MRI/ERUS and careful intraoperative exploration are required to direct surgical treatment and to reduce local recurrence. Optimal selection of surgical approach also is very important to reduce local recurrence. Presacral lesions attached to the sacrococcyx or rectum require simultaneous partial resection of the sacrococcyx or rectum to reduce local recurrence.

Entities:  

Mesh:

Year:  2011        PMID: 21607819     DOI: 10.1007/s00268-011-1155-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  Presacral tumors and cysts in adults.

Authors:  B E Uhlig; R L Johnson
Journal:  Dis Colon Rectum       Date:  1975-10       Impact factor: 4.585

2.  Unusual retrorectal lesion.

Authors:  Selliah C Kanthan; Rani Kanthan
Journal:  Asian J Surg       Date:  2004-04       Impact factor: 2.767

3.  Laparoscopic and perineal excision of an infected "dumb-bell" shaped retrorectal epidermoid cyst.

Authors:  Chinnusamy Palanivelu; Muthukumaran Rangarajan; Rangasamy Senthilkumar; Madhupalayam V Madankumar; Shankar Annapoorni
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2008-02       Impact factor: 1.878

4.  Tailgut cyst initially misdiagnosed as ovarian tumor.

Authors:  Benjamin Piura; Alex Rabinovich; Igor Sinelnikov; Bertha Delgado
Journal:  Arch Gynecol Obstet       Date:  2005-10-13       Impact factor: 2.344

Review 5.  Tumors of the retrorectal space.

Authors:  Kristina G Hobson; Vafa Ghaemmaghami; John P Roe; James E Goodnight; Vijay P Khatri
Journal:  Dis Colon Rectum       Date:  2005-10       Impact factor: 4.585

6.  Presacral tumors: a practical classification and treatment of a unique and heterogeneous group of diseases.

Authors:  Dina Lev-Chelouche; Mordechai Gutman; Gideon Goldman; Einat Even-Sapir; Isaac Meller; Josephine Issakov; Joseph M Klausner; Micha Rabau
Journal:  Surgery       Date:  2003-05       Impact factor: 3.982

7.  [Presacral tumors. Analysis of 20 surgically treated patients].

Authors:  Enrique Canelles; José V Roig; Miriam Cantos; Juan García Armengol; Erica Barreiro; Francisco L Villalba; María Dolores Ruiz; Vicente Pla
Journal:  Cir Esp       Date:  2009-05-07       Impact factor: 1.653

8.  Vestigial retrorectal cystic tumors in adults: a review of 30 cases.

Authors:  J-P Grandjean; G-A Mantion; D Guinier; L Henry; S Cherki; L Passebois; P Chalabreysse; G Viennet; B Pujol; J Chabanon
Journal:  Gastroenterol Clin Biol       Date:  2008-05-15

9.  Two-stage therapy in the treatment of sacral tumors.

Authors:  P Wuisman; A Härle; H H Matthiass; A Roessner; R Erlemann; M Reiser
Journal:  Arch Orthop Trauma Surg       Date:  1989       Impact factor: 3.067

10.  A rare case of presacral cystic neuroblastoma in an infant.

Authors:  Miho Watanabe; Hiroaki Komuro; Michio Kaneko; Tetsuo Hori; Yukihiro Tatekawa; Sumi Kudo; Yasuhisa Urita; Seiichiro Inoue; Manabu Minami; Masato Sugano
Journal:  J Pediatr Surg       Date:  2008-07       Impact factor: 2.545

View more
  4 in total

1.  A hundred patients with vertical rectus abdominis myocutaneous (VRAM) flap for pelvic reconstruction after total pelvic exenteration.

Authors:  R E Horch; W Hohenberger; A Eweida; U Kneser; K Weber; A Arkudas; S Merkel; J Göhl; J P Beier
Journal:  Int J Colorectal Dis       Date:  2014-04-22       Impact factor: 2.571

Review 2.  Retrorectal Tumors: A Comprehensive Literature Review.

Authors:  Seong Kyu Baek; Grace Soon Hwang; Alessio Vinci; Mehraneh D Jafari; Fariba Jafari; Zhobin Moghadamyeghaneh; Alessio Pigazzi
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

3.  Laparoscopic approach for retrorectal tumors.

Authors:  Marius Nedelcu; Anamaria Andreica; Mehdi Skalli; Isabelle Pirlet; Françoise Guillon; David Nocca; Jean Michel Fabre
Journal:  Surg Endosc       Date:  2013-06-01       Impact factor: 4.584

4.  Application of the da Vinci surgical robot system in presacral nerve sheath tumor treatment.

Authors:  Feifei Pu; Zhicai Zhang; Zhaohui Chen; Kailin Cai; Baichuan Wang; Qiang Wu; Deyao Shi; Jianxiang Liu; Zengwu Shao
Journal:  Oncol Lett       Date:  2020-08-19       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.